SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

24 hedge funds and large institutions have $4.67M invested in Seelos Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$633K
2
+$187K
3
+$176K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$109K
5
GCP
GSA Capital Partners
United Kingdom
+$26K

Top Sellers

1
-$363K
2
-$137K
3
-$97K
4
SIM
Spark Investment Management
New York
-$24K
5
DC
Davenport & Co
Virginia
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
1
2